Vutrisiran Lowers Cardiovascular Events, Mortality in HELIOS-B Analysis
Latest analysis of the HELIOS-B trial finds vutrisiran significantly lowers mortality and cardiovascular events in patients with ATTR-CM.
Related Articles
The Medical Sisterhood—The Global Sisterhood: When She Speaks the World Listens
Melinda Gooderham, MD, MSc, joins The Medical Sisterhood to discuss balancing mentorship, leadership, and family, as well as the empowerment of women in the medical…
Evidence for OX40-OX40L Axis Inhibition for Atopic Dermatitis, with Christopher Bunick, MD, PhD
This Q&A interview at RAD 2025 features a discussion about a talk titled ‘Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic…
ADA Symposium Focuses on New Guidelines for SOC of Overweight and Obesity
New ADA guidelines enhance obesity care, focusing on personalized treatment, bias reduction, and inclusive practices to improve patient outcomes.
Naps at Noon Linked to Mortality Risk in Older Adults, with Chenlu Gao, PhD
A study presented at SLEEP 2025 found longer and more variable napping patterns are associated with increased all-cause mortality in middle-to-older aged adults.
FDA Extends Review Period of Ruxolitinib Cream for Children with Atopic Dermatitis
This update by FDA officials extends the review period for ruxolitinib cream as a treatment for atopic dermatitis in children aged 2-11 years.
Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms
Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI platforms.
Updates in Obesity Hypoventilation Syndrome Diagnosis, with Atul Malhotra, MD
At SLEEP 2025, Malhotra shared updates on diagnosing and managing OHS, including the role of bicarbonate, PAP use, and weight loss.
HCPLive – Clinical news for connected physicians
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Anaphylaxis | Medical News & Expert Insight | HCPLive
The anaphylaxis condition center is a comprehensive resource for clinical news and expert insights on anaphylaxis. Read more at HCPLive.
Naps at Noon Linked to Mortality Risk in Older Adults, with Chenlu Gao, PhD
A study presented at SLEEP 2025 found longer and more variable napping patterns are associated with increased all-cause mortality in middle-to-older aged adults.